Skip to main content

Advertisement

Log in

HIV and Chronic Methamphetamine Dependence Affect Cerebral Blood Flow

  • ORIGINAL ARTICLE
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

Abstract

Human immunodeficiency virus (HIV) and methamphetamine (METH) dependence are independently associated with neuronal dysfunction. The coupling between cerebral blood flow (CBF) and neuronal activity is the basis of many task-based functional neuroimaging techniques. We examined the interaction between HIV infection and a previous history of METH dependence on CBF within the lenticular nuclei (LN). Twenty-four HIV−/METH−, eight HIV−/METH+, 24 HIV+/METH−, and 15 HIV+/METH+ participants performed a finger tapping paradigm. A multiple regression analysis of covariance assessed associations and two-way interactions between CBF and HIV serostatus and/or previous history of METH dependence. HIV+ individuals had a trend towards a lower baseline CBF (−10%, p = 0.07) and greater CBF changes for the functional task (+32%, p = 0.01) than HIV− subjects. Individuals with a previous history of METH dependence had a lower baseline CBF (−16%, p = 0.007) and greater CBF changes for a functional task (+33%, p = 0.02). However, no interaction existed between HIV serostatus and previous history of METH dependence for either baseline CBF (p = 0.53) or CBF changes for a functional task (p = 0.10). In addition, CBF and volume in the LN were not correlated. A possible additive relationship could exist between HIV infection and a history of METH dependence on CBF with a previous history of METH dependence having a larger contribution. Abnormalities in CBF could serve as a surrogate measure for assessing the chronic effects of HIV and previous METH dependence on brain function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Allison JD, Meador KJ, Loring DW, Figueroa RE, Wright JC (2000) Functional MRI cerebral activation and deactivation during finger movement. Neurology 54:135–142

    PubMed  CAS  Google Scholar 

  • Ances BM, Ellis RJ (2007) Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 27:86–92

    Article  PubMed  Google Scholar 

  • Ances BM, Roc AC, Wang J, Korczykowski M, Okawa J, Stern J, Kim J, Wolf R, Lawler K, Kolson DL, Detre JA (2006) Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients. Neurology 66:862–866

    Article  PubMed  CAS  Google Scholar 

  • Ances BM, Leontiev O, Perthen JE, Liang C, Lansing AE, Buxton RB (2008a) Regional differences in the coupling of cerebral blood flow and oxygen metabolism changes in response to activation: implications for BOLD-fMRI. Neuroimage 39:1510–1521

    Article  PubMed  Google Scholar 

  • Ances BM, Roc AC, Korczykowski M, Wolf RL, Kolson DL (2008b) Combination antiretroviral therapy modulates the blood oxygen level-dependent amplitude in human immunodeficiency virus-seropositive patients. J Neurovirol 14:418–424

    Article  PubMed  CAS  Google Scholar 

  • Ances BM, Sisti D, Vaida F, Liang CL, Leontiev O, Perthen JE, Buxton RB, Benson D, Smith DM, Little SJ, Richman DD, Moore DJ, Ellis RJ (2009) Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain. Neurology 73:702–708

    Article  PubMed  CAS  Google Scholar 

  • Ances B, Vaida F, Ellis R, Buxton R (2010) Test-retest stability of calibrated BOLD-fMRI in HIV- and HIV+ subjects. Neuroimage 54:2156–2162

    Article  PubMed  Google Scholar 

  • Bamford NS, Zhang H, Joyce JA, Scarlis CA, Hanan W, Wu NP, Andre VM, Cohen R, Cepeda C, Levine MS, Harleton E, Sulzer D (2008) Repeated exposure to methamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministration. Neuron 58:89–103

    Article  PubMed  CAS  Google Scholar 

  • Bokkers RP, van der Worp HB, Mali WP, Hendrikse J (2009) Noninvasive MR imaging of cerebral perfusion in patients with a carotid artery stenosis. Neurology 73:869–875

    Article  PubMed  CAS  Google Scholar 

  • Boynton GM, Engel SA, Glover GH, Heeger DJ (1996) Linear systems analysis of functional magnetic resonance imaging in human V1. J Neurosci 16:4207–4221

    PubMed  CAS  Google Scholar 

  • Burock MA, Dale AM (2000) Estimation and detection of event-related fMRI signals with temporally correlated noise: a statistically efficient and unbiased approach. Hum Brain Mapp 11:249–260

    Article  PubMed  CAS  Google Scholar 

  • Buxton RB (2010) Interpreting oxygenation-based neuroimaging signals: the importance and the challenge of understanding brain oxygen metabolism. Front Neuroenergetics 2:8

    PubMed  Google Scholar 

  • Carey CL, Woods SP, Rippeth JD, Gonzalez R, Heaton RK, Grant I (2006) Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection. AIDS Behav 10:185–190

    Article  PubMed  Google Scholar 

  • Chalela JA, Alsop DC, Gonzalez-Atavales JB, Maldjian JA, Kasner SE, Detre JA (2000) Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke 31:680–687

    Article  PubMed  CAS  Google Scholar 

  • Chana G, Everall IP, Crews L, Langford D, Adame A, Grant I, Cherner M, Lazzaretto D, Heaton R, Ellis R, Masliah E (2006) Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology 67:1486–1489

    Article  PubMed  CAS  Google Scholar 

  • Chang L, Ernst T, Leonido-Yee M, Speck O (2000) Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex. Neurology 54:389–396

    PubMed  CAS  Google Scholar 

  • Chang L, Speck O, Miller EN, Braun J, Jovicich J, Koch C, Itti L, Ernst T (2001) Neural correlates of attention and working memory deficits in HIV patients. Neurology 57:1001–1007

    PubMed  CAS  Google Scholar 

  • Chang L, Ernst T, Speck O, Patel H, DeSilva M, Leonido-Yee M, Miller EN (2002) Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res 114:65–79

    Article  PubMed  Google Scholar 

  • Chang L, Tomasi D, Yakupov R, Lozar C, Arnold S, Caparelli E, Ernst T (2004) Adaptation of the attention network in human immunodeficiency virus brain injury. Ann Neurol 56:259–272

    Article  PubMed  Google Scholar 

  • Chang L, Ernst T, Speck O, Grob CS (2005) Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry 162:361–369

    Article  PubMed  Google Scholar 

  • Chang L, Alicata D, Ernst T, Volkow N (2007) Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102(Suppl 1):16–32

    Article  PubMed  Google Scholar 

  • Cherner M, Letendre S, Heaton RK, Durelle J, Marquie-Beck J, Gragg B, Grant I (2005) Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology 64:1343–1347

    Article  PubMed  CAS  Google Scholar 

  • Cherner M, Suarez P, Casey C, Deiss R, Letendre S, Marcotte T, Vaida F, Atkinson JH, Grant I, Heaton RK (2010) Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults. Drug Alcohol Depend 106:154–163

    Article  PubMed  Google Scholar 

  • Chiarelli PA, Bulte DP, Piechnik S, Jezzard P (2007) Sources of systematic bias in hypercapnia-calibrated functional MRI estimation of oxygen metabolism. Neuroimage 34:35–43

    Article  PubMed  Google Scholar 

  • Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R, Taylor M, Thompson P, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B (2010) Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. J Neurovirol 16:25–32

    Article  PubMed  CAS  Google Scholar 

  • Cox RW (1996) AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 29:162–173

    Article  PubMed  CAS  Google Scholar 

  • Domino EF, Minoshima S, Guthrie S, Ohl L, Ni L, Koeppe RA, Zubieta JK (2000) Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse 38:313–321

    Article  PubMed  CAS  Google Scholar 

  • Ellis RJ, Moore DJ, Childers ME, Letendre S, McCutchan JA, Wolfson T, Spector SA, Hsia K, Heaton RK, Grant I (2002) Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol 59:923–928

    Article  PubMed  Google Scholar 

  • Fama R, Rosenbloom MJ, Nichols BN, Pfefferbaum A, Sullivan EV (2009) Working and episodic memory in HIV infection, alcoholism, and their comorbidity: baseline and 1-year follow-up examinations. Alcohol Clin Exp Res 33:1815–1824

    Article  PubMed  Google Scholar 

  • Flora G, Lee YW, Nath A, Hennig B, Maragos W, Toborek M (2003) Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain. Exp Neurol 179:60–70

    Article  PubMed  CAS  Google Scholar 

  • Fujimura RK, Goodkin K, Petito CK, Douyon R, Feaster DJ, Concha M, Shapshak P (1997) HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia. J Acquir Immune Defic Syndr Hum Retrovirol 16:146–152

    Article  PubMed  CAS  Google Scholar 

  • Jernigan TL, Gamst AC, Archibald SL, Fennema-Notestine C, Mindt MR, Marcotte TD, Heaton RK, Ellis RJ, Grant I (2005) Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry 162:1461–1472

    Article  PubMed  Google Scholar 

  • Juengst SB, Aizenstein HJ, Figurski J, Lopez OL, Becker JT (2007) Alterations in the hemodynamic response function in cognitively impaired HIV/AIDS subjects. J Neurosci Methods 163:208–212

    Article  PubMed  Google Scholar 

  • Kastrup A, Kruger G, Neumann-Haefelin T, Glover GH, Moseley ME (2002) Changes of cerebral blood flow, oxygenation, and oxidative metabolism during graded motor activation. Neuroimage 15:74–82

    Article  PubMed  Google Scholar 

  • Kumar AM, Fernandez J, Singer EJ, Commins D, Waldrop-Valverde D, Ownby RL, Kumar M (2009) Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. J Neurovirol 15:257–274

    Article  PubMed  CAS  Google Scholar 

  • Langford D, Grigorian A, Hurford R, Adame A, Crews L, Masliah E (2004) The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons. J Neurovirol 10:327–337

    Article  PubMed  CAS  Google Scholar 

  • Marshall JF, O’Dell SJ, Weihmuller FB (1993) Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity. J Neural Transm Gen Sect 91:241–254

    Article  PubMed  CAS  Google Scholar 

  • Mumford JA, Hernandez-Garcia L, Lee GR, Nichols TE (2006) Estimation efficiency and statistical power in arterial spin labeling fMRI. Neuroimage 33:103–114

    Article  PubMed  Google Scholar 

  • Nath A, Maragos WF, Avison MJ, Schmitt FA, Berger JR (2001) Acceleration of HIV dementia with methamphetamine and cocaine. J Neurovirol 7:66–71

    Article  PubMed  CAS  Google Scholar 

  • Navia BA, Cho ES, Petito CK, Price RW (1986) The AIDS dementia complex: II. Neuropathology. Ann Neurol 19:525–535

    Article  PubMed  CAS  Google Scholar 

  • Osawa A, Maeshima S, Shimamoto Y, Maeshima E, Sekiguchi E, Kakishita K, Ozaki F, Moriwaki H (2004) Relationship between cognitive function and regional cerebral blood flow in different types of dementia. Disabil Rehabil 26:739–745

    Article  PubMed  Google Scholar 

  • Perthen JE, Bydder M, Restom K, Liu TT (2008a) SNR and functional sensitivity of BOLD and perfusion-based fMRI using arterial spin labeling with spiral SENSE at 3 T. Magn Reson Imaging 26:513–522

    Article  PubMed  Google Scholar 

  • Perthen JE, Lansing AE, Liau J, Liu TT, Buxton RB (2008b) Caffeine-induced uncoupling of cerebral blood flow and oxygen metabolism: a calibrated BOLD fMRI study. Neuroimage 40:237–247

    Article  PubMed  Google Scholar 

  • Pohl P, Vogl G, Fill H, Rossler H, Zangerle R, Gerstenbrand F (1988) Single photon emission computed tomography in AIDS dementia complex. J Nucl Med 29:1382–1386

    PubMed  CAS  Google Scholar 

  • Ramirez SH, Potula R, Fan S, Eidem T, Papugani A, Reichenbach N, Dykstra H, Weksler BB, Romero IA, Couraud PO, Persidsky Y (2009) Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells. J Cereb Blood Flow Metab 29:1933–1945

    Article  PubMed  CAS  Google Scholar 

  • Restom K, Perthen JE, Liu TT (2008) Calibrated fMRI in the medial temporal lobe during a memory-encoding task. Neuroimage 40:1495–1502

    Article  PubMed  Google Scholar 

  • Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, Wolfson T, Grant I (2004) Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 10:1–14

    Article  PubMed  CAS  Google Scholar 

  • Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, Farmer A, Jablenski A, Pickens R, Regier DA et al (1988) The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 45:1069–1077

    PubMed  CAS  Google Scholar 

  • Rosenbloom MJ, Sullivan EV, Sassoon SA, O’Reilly A, Fama R, Kemper CA, Deresinski S, Pfefferbaum A (2007) Alcoholism, HIV infection, and their comorbidity: factors affecting self-rated health-related quality of life. J Stud Alcohol Drugs 68:115–125

    PubMed  Google Scholar 

  • Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, Grant I (2007) Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 17:275–297

    Article  PubMed  Google Scholar 

  • Simon SL, Dean AC, Cordova X, Monterosso JR, London ED (2010) Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence. J Stud Alcohol Drugs 71:335–344

    PubMed  Google Scholar 

  • Spitzer RL, Williams JB, Gibbon M, First MB (1992) The Structured Clinical Interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry 49:624–629

    PubMed  CAS  Google Scholar 

  • Stephans SE, Yamamoto BK (1994) Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 17:203–209

    Article  PubMed  CAS  Google Scholar 

  • Takaki M, Ujike H, Kodama M, Takehisa Y, Yamamoto A, Kuroda S (2001) Increased expression of synaptophysin and stathmin mRNAs after methamphetamine administration in rat brain. Neuroreport 12:1055–1060

    Article  PubMed  CAS  Google Scholar 

  • Taylor MJ, Schweinsburg BC, Alhassoon OM, Gongvatana A, Brown GG, Young-Casey C, Letendre SL, Grant I (2007) Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy. J Neurovirol 13:150–159

    Article  PubMed  CAS  Google Scholar 

  • Vafaee MS, Gjedde A (2004) Spatially dissociated flow-metabolism coupling in brain activation. Neuroimage 21:507–515

    Article  PubMed  Google Scholar 

  • Wang GJ, Chang L, Volkow ND, Telang F, Logan J, Ernst T, Fowler JS (2004) Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 127:2452–2458

    Article  PubMed  Google Scholar 

  • Wang J, Zhang Y, Wolf RL, Roc AC, Alsop DC, Detre JA (2005) Amplitude-modulated continuous arterial spin-labeling 3.0-T perfusion MR imaging with a single coil: feasibility study. Radiology 235:218–228

    Article  PubMed  Google Scholar 

  • Westover AN, McBride S, Haley RW (2007) Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch Gen Psychiatry 64:495–502

    Article  PubMed  Google Scholar 

  • Zubieta JK, Heitzeg MM, Xu Y, Koeppe RA, Ni L, Guthrie S, Domino EF (2005) Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence. Am J Psychiatry 162:567–577

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a Dana Foundation Brain Immuno Imaging Award (DF3857-41880; B.A.) and NIH grants 1K23MH081786 and 1R01NR012657 (B.A.), NS-36722 and NS-42069 (R.B., C.G., and C.L.), MH22005 and AI47033 (F.V.), P30 MH62512 (M.C., R.E., I.G., F,V., and HNRC Group), and P01 DA12065. The authors would like to thank the contributions of study participants and staff at the HNRC and Translational Methamphetamine AIDS Research Center (P50 DA26306), San Diego, CA, USA. The HNRC Group is affiliated with the University of California, San Diego, the Naval Hospital, San Diego, the Veterans Affairs San Diego Healthcare System and includes Director: Igor Grant, M.D.; Co-Directors: J. Hampton Atkinson, M.D., Ronald J. Ellis, M.D., Ph.D., and J. Allen McCutchan, M.D.; Center Manager: Thomas D. Marcotte, Ph.D.; Assistant Center Manager: Jennifer Marquie-Beck; Business Manager: Melanie Sherman; Naval Hospital San Diego: Braden R. Hale, M.D., M.P.H. (P.I.); Neuromedical Component: Ronald J. Ellis, M.D., Ph.D. (P.I.), J. Allen McCutchan, M.D., Scott Letendre, M.D., Edmund Capparelli, Pharm.D., Rachel Schrier, Ph.D., and Terry Alexander, R.N.; Neurobehavioral Component: Robert K. Heaton, Ph.D. (P.I.), Mariana Cherner, Ph.D., Steven Paul Woods, Psy.D., David J. Moore, Ph.D.; Matthew Dawson, and Donald Franklin; Neuroimaging Component: Terry Jernigan, Ph.D. (P.I.), Christine Fennema-Notestine, Ph.D., Sarah L. Archibald, M.A., Marc Jacobson, Ph.D., Jacopo Annese, Ph.D., and Michael J. Taylor, Ph.D.; Neurobiology Component: Eliezer Masliah, M.D. (P.I.), Ian Everall, FRCPsych., FRCPath., Ph.D., and Cristian Achim, M.D., Ph.D.; Neurovirology Component: Douglas Richman, M.D., (P.I.) and David M. Smith, M.D.; International Component: J. Allen McCutchan, M.D., (P.I.); Developmental Component: Cristian Achim, MD, Ph.D. (P.I.) and Stuart Lipton, M.D., Ph.D.; Clinical Trials Component: J. Allen McCutchan, M.D., J. Hampton Atkinson, M.D., Ronald J. Ellis, M.D., Ph.D., and Scott Letendre, M.D.; Participant Accrual and Retention Unit: J. Hampton Atkinson, M.D. (P.I.) and Rodney von Jaeger, M.P.H.; Data Management Unit: Anthony C. Gamst, Ph.D. (P.I.) and Clint Cushman (Data Systems Manager); Statistics Unit: Ian Abramson, Ph.D. (P.I.), Florin Vaida, Ph.D., Tanya Wolfson, MS, and Reena Deutsch, Ph.D.

Disclaimer

There are no conflicts of interest.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Beau M. Ances.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ances, B.M., Vaida, F., Cherner, M. et al. HIV and Chronic Methamphetamine Dependence Affect Cerebral Blood Flow. J Neuroimmune Pharmacol 6, 409–419 (2011). https://doi.org/10.1007/s11481-011-9270-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-011-9270-y

Keywords

Navigation